These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1741710)

  • 21. Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy.
    Oka M; Hazama S; Suzuki M; Ogura Y; Kobayashi N; Suzuki T
    Hepatogastroenterology; 1995; 42(5):561-6. PubMed ID: 8751216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.
    Velotti F; Tubaro A; Stoppacciaro A; Pettinato A; Morrone S; Bossola P; Napolitano T; Miano L; Ruco L; Piccoli M
    Ann Ist Super Sanita; 1990; 26(3-4):411-21. PubMed ID: 2091503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local activation of immune response in bladder cancer patients treated with intraarterial infusion of recombinant interleukin-2.
    Velotti F; Stoppacciaro A; Ruco L; Tubaro A; Pettinato A; Morrone S; Napolitano T; Bossola PC; Franks CR; Palmer P
    Cancer Res; 1991 May; 51(9):2456-62. PubMed ID: 2015606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Superselective intraarterial chemotherapy using low dose CBDCA and Pirarubicin with concurrent radiotherapy for head and neck cancer].
    Ito K; Shiba H; Fujiwara K; Kunimoto Y; Tanimoto S; Higami Y; Kitano H
    Nihon Jibiinkoka Gakkai Kaiho; 2005 Mar; 108(3):195-201. PubMed ID: 15828284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
    Vokes EE; Mick R; Lester EP; Panje WR; Weichselbaum RR
    J Clin Oncol; 1991 Aug; 9(8):1376-84. PubMed ID: 2072141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
    Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
    Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
    Lauria F; Raspadori D; Ventura MA; Rondelli D; Zinzani PL; Gherlinzoni F; Miggiano MC; Fiacchini M; Rosti G; Rizzi S; Tura S
    Bone Marrow Transplant; 1996 Jul; 18(1):79-85. PubMed ID: 8831999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermochemotherapy in inoperable head and neck cancer.
    Davis RK; Gibbs FA; Sapozink MD; Farver M; Harker G
    Otolaryngol Head Neck Surg; 1990 Dec; 103(6):897-901. PubMed ID: 2126122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiotherapy plus a combination of cisplatin and 5-fluorouracil for locally advanced head and neck neoplasms. Study of feasibility and preliminary results].
    Colombo A; Crispino S; Tancini G; Personeni A; Taino R; Sarti E; Barni S; Lissoni P; Placa F; Mazzola P
    Radiol Med; 1990 Nov; 80(5):713-8. PubMed ID: 2267392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.
    Weiss GR; Margolin KA; Aronson FR; Sznol M; Atkins MB; Dutcher JP; Gaynor ER; Boldt DH; Doroshow JH; Bar MH
    J Clin Oncol; 1992 Feb; 10(2):275-81. PubMed ID: 1732429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness and indication of superselective intra-arterial chemotherapy via the radial artery for advanced head and neck cancer--aN indication for inaccessible to treatment with seldingers method].
    Yokoyama J; Ito S; Ohba S; Fujimaki M; Ikeda K; Hanaguri M
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Jun; 115(6):625-31. PubMed ID: 22844823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A phase 2 study of recombinant interleukin 2 (S-6820) for head and neck cancer].
    Sawaki S
    Gan No Rinsho; 1990 Feb; 36(2):111-20. PubMed ID: 2308207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancers.
    Imai S; Kajihara Y; Munemori O; Kamei T; Mori T; Handa T; Akisada K; Orita Y
    Eur J Radiol; 1995 Dec; 21(2):94-9. PubMed ID: 8850500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma.
    Ratto GB; Zino P; Mirabelli S; Minuti P; Aquilina R; Fantino G; Spessa E; Ponte M; Bruzzi P; Melioli G
    Cancer; 1996 Jul; 78(2):244-51. PubMed ID: 8673999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of therapeutic potential of interleukin 2-expanded tumor-infiltrating lymphocytes in squamous cell carcinoma of the head and neck.
    Boscia R; Chen K; Johnson JT; Whiteside TL
    Ann Otol Rhinol Laryngol; 1988; 97(4 Pt 1):414-21. PubMed ID: 3261562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies.
    Wanebo HJ; Rathore R; Chougule P; DiSiena MR; Koness RJ; McRae RG; Nigri PT; Radie-Keane K; Ready N
    Ann Surg Oncol; 2011 Nov; 18(12):3479-85. PubMed ID: 21553142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.